|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Umair MallickPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 1st ed. 2022 Weight: 0.907kg ISBN: 9783030900649ISBN 10: 3030900649 Pages: 414 Publication Date: 11 February 2022 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsEpidemiology.- Virology Of COVID 19.- Clinical Features And Complications Of COVID 19.-Treatment Options In Covid 19.- Inflammation And COVID 19.- Renin Angiotensin System And COVID 19.- Pathogenetic Mechanisms In Non-Cardiovascular Complications.- Cytokines And Viral Damage In COVID 19.- Thrombosis In COVID 19.- Angiotensin Converting Enzyme 2 In COVID 19.- Regulatory Systems And COVID 19.- Miscellaneous Novel Mechanisms In COVID 19.- Myocardial Injury And Acute Coronary Syndromes In COVID 19.- Heart Failure, Hypertension And Arrhythmias In COVID 19.- Patients With Cardiometabolic Diseases And COVID 19.- Older Age And COVID 19.- Gender Dichotomy And COVID 19.- Quality Of Research In COVID 19.- Conclusion.ReviewsAuthor InformationDr. Umair Mallick is a consultant cardiologist with an international portfolio in academic and industrial clinical research. He has made significant contributions to science and the medical fields internationally by serving clinical and healthcare institutions, academia, the pharmaceutical industry, and actively engaging in multiple important research initiatives and collaborations globally. His clinical expertise includes complex hypertension, heart failure, stroke, and cardiovascular disease prevention, and has a special interest in the older age population. He has held several positions as a clinician and clinical researcher in prestigious world-class academic, and healthcare institutions including the National Health Services (NHS) of the United Kingdom and Europe, as well as pharmaceutical industrial institutions. He has served as an advisor and member of panels for several national and international academic organizations, has peer-reviewed for highly ranking prestigiousmedical journals, and has published in the field of cardiology, metabolic diseases, and clinical trials. Dr. Mallick has designed and led various initiatives for the improvement of the quality of care of patients, education programs and clinical care pathways, research protocols, and clinical guidelines. He has advanced level expertise in designing, conducting, and analysis of large international complex clinical trials, and epidemiological studies, and has served in key areas of the drug discovery process, including collaboration with ethics and regulatory bodies in the domain of clinical research. At present, he is the Director at Heart Health and Research International (HHRI) Ltd and ad hoc consultant with NHS hospitals in the United Kingdom. Tab Content 6Author Website:Countries AvailableAll regions |